Sep 18, 2025
Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Sep 16, 2025
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
Sep 09, 2025
Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit
Aug 18, 2025
Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.
Aug 14, 2025
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
Jul 15, 2025
Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025
Mar 27, 2025
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
Mar 13, 2025
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
Mar 06, 2025
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit
Mar 03, 2025
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
Feb 21, 2025
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
Jan 07, 2025
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025
Dec 10, 2024
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
Nov 07, 2024
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
Oct 25, 2024
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
Oct 21, 2024
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
Sep 24, 2024
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
Sep 05, 2024
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
Aug 15, 2024
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
Aug 08, 2024
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results